All Curated Mutation Sites in HIV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
IN
  
RT
  
LTR
  
CA
  
Gag
  
Nef
  
Env
  
gp120
  
gp160
  
gp41
  
gp140
  
MA
  
Pol
  
PR
  
Rev
  
Tat
  
Vpu
  
Vif
  
Vpr
  

Keyword: HIV Infections-21694608
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 21694608 A62V
RT
gag-pol
HIV Infections
D
G
C
L
T
View
2 21694608 D67N
RT
gag-pol
HIV Infections
D
G
C
L
T
View
3 21694608 G190A
RT
gag-pol
HIV Infections
D
G
C
L
T
View
4 21694608 G190S
RT
gag-pol
HIV Infections
D
G
C
L
T
View
5 21694608 K103N
RT
gag-pol
HIV Infections
D
G
C
L
T
View
6 21694608 K219E
RT
gag-pol
HIV Infections
D
G
C
L
T
View
7 21694608 K65R
RT
gag-pol
HIV Infections
D
G
C
L
T
View
8 21694608 K70R
RT
gag-pol
HIV Infections
D
G
C
L
T
View
9 21694608 M184I
RT
gag-pol
HIV Infections
D
G
C
L
T
View
10 21694608 M184V
RT
gag-pol
HIV Infections
D
G
C
L
T
View
11 21694608 N348I
RT
gag-pol
HIV Infections
D
G
C
L
T
View
12 21694608 V106M
RT
gag-pol
HIV Infections
D
G
C
L
T
View
13 21694608 Y188C
RT
gag-pol
HIV Infections
D
G
C
L
T
View
14 21694608 Y188L
RT
gag-pol
HIV Infections
D
G
C
L
T
View
Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.